Search This Blog

Saturday 3 January 2015

The Divine law and blood IX:Going mainstream?

Bloodless’ surgery option reveals unexpected benefits




By Sharon Kirkey, Postmedia News
When doctors at a New Jersey hospital pioneered a “bloodless” surgery program for patients who refused blood transfusions on religious grounds, they discovered something totally unexpected: Jehovah’s Witnesses, who would choose death over a transfusion, recovered just as well as transfused patients — and in many cases, even better.
They suffered fewer post-surgery complications, spent less time on mechanical breathing machines and had shorter stays in intensive care.
Recently, doctors from the Cleveland Clinic in Ohio reported that Jehovah’s Witnesses who refused blood transfusions while undergoing cardiac surgery were significantly less likely to need another operation for bleeding compared with non-Witnesses who were transfused. They were also less likely to suffer a post-op heart attack or kidney failure.
Are the Jehovah’s Witnesses onto something?
In cases of massive “bleed outs” from trauma or hemorrhage, or for patients with leukemia or other cancers, blood transfusions can be life-saving.
At the same time, experts say there is remarkably little evidence to show which patients — short of those suddenly losing large amounts of blood — actually benefit from blood transfusions.
In fact, a growing body of research links transfusions with an increased risk of post-surgery infections, cardiac arrest, heart attack, stroke, kidney failure, lung injury, multi-organ failure and death.
Transfused patients spend more time in hospital than those who don’t get blood; they spend more time in intensive care units connected to ventilators; and have a higher risk of acute respiratory distress, where the lungs become saturated with fluid, preventing enough oxygen from getting to the lungs and into the blood.
Studies suggest that up to half of all red-blood-cell transfusions may be unnecessary. Needless transfusions not only waste blood, they expose patients to risks — including potentially life-threatening human errors that are occurring at every step in the transfusion chain.
Three decades after Canada’s catastrophic tainted-blood tragedy left 2,000 people infected with HIV and another 30,000 with hepatitis C, the greatest threat to patients today isn’t the risk of contracting an infectious disease from blood, experts now say.
It’s getting blood they don’t need.

Overused medical procedure?

From ancient times to the late 19th century, sickness was treated by blood loss: using lances or leeches to bleed the body of suspected diseases that caused “bad” blood.
Today, we call blood the “gift of life.” The belief that blood is almost a magical cure is still held by many.
“In the minds of many people, blood is life, and giving people blood must help life,” says Dr. Jacques Lacroix, a professor of pediatrics at the University of Montreal and a national and international pioneer in pediatric critical care and research.
“But it does not work like that.”
In fact, transfusions have been identified by the American Medical Association as among the top five overused procedures in medicine.
In Canada, about 850,000 units of red blood cells, and 102,000 doses of platelets, were transfused into patients outside Quebec in 2011-2012, according to estimates compiled by the Canadian Blood Services for Postmedia News. (Hema-Quebec, which runs the province’s blood system, collected 252,340 units of blood from donors in 2011-2012; more than 526,000 blood products were shipped to hospitals.)
Canadian researchers have led the world in showing that patients benefit from more restrictive blood use.  But, there is no single, unified national system to determine how much of the blood distributed by the Canadian Blood Services is actually transfused, who gets it and whether it’s being given for the right reasons.
Studies suggest that, even when patients have the same underlying condition, the same surgery and the same blood loss, transfusion rates vary widely from hospital to hospital for the same operation.
For example, a review of more than 8,000 patients who underwent cardiac surgery in British Columbia between 2008 and 2010 found that the proportion of patients who received red-blood-cell transfusions ranged from 35 to 66 per cent.
A provincewide audit of Ontario hospitals published in May concluded that nearly one in three transfusions of frozen plasma — the liquid portion of blood that contains clotting factors to help control bleeding during surgery — was unnecessary.
In Calgary, knee replacement patients are being transfused at rates ranging from two per cent of patients to 25 per cent, depending on the surgeon.
Many transfusions don’t meet even minimum published guidelines, experts say. Many patients receive not one, but multiple units of blood, increasing their risk of fluid overload, where the extra blood overwhelms the heart’s ability to pump it through the body. Transfusion-related circulatory overload is one of the leading causes of transfusion-related death.
In some areas of medicine, including cardiac surgery, no clear consensus exists on when patients should be transfused.
“What we are sure of, however, is that there is a huge variation in transfusion rates across Canada for cardiac surgery patients of the same risk profile, and this is very difficult to explain,” says Dr. Fraser Rubens, a cardiac surgeon at the University of Ottawa Heart Institute.

Limiting the use of blood

As concern mounts over the dangers of unnecessary transfusions, hospitals have begun using strategies to reduce the use of blood.
For example:
• Blood draining out from under surgical wounds is being siphoned off, re-processed and then re-infused back into the patient.
• Surgeons are using drugs to prevent bleeding and improve blood clotting.
• Surgeons are operating through laparoscopes and other minimally invasive tools to reduce bleeding from large surgical wounds.
• Patients are being screened and treated for anemia with supplements or drugs that boost the bone marrow to produce red blood cells before they get into the operating room.
The variability in transfusion rates is slowly falling. But doctors have been slow to adapt. “The biggest challenge is trying to change the behaviour of physicians,” says Dr. Alan Tinmouth, a hematologist and scientist at the Ottawa Hospital Research Institute. “People are being transfused at hemoglobin levels higher than they need to be.”
Many doctors remain unconvinced of the potential dangers of transfusions. None of the studies suggesting increased risks of harm prove cause-and-effect, just an association, they point out. What’s more, patients who are transfused tend to be sicker to begin with, so it’s no surprise that they don’t recover as well as non-transfused patients, they argue.
But Dr. Paul Marik says numerous studies have shown that the more blood given, the worse the outcome.
In a widely cited study published in 2008, Marik analyzed 45 studies involving nearly 300,000 patients. In 42 of those studies, the risks of red-blood-cell transfusions outweighed the benefits. Transfused patients were twice as likely to develop infections, multi-organ failure and acute respiratory distress than the non-transfused.
Critics of his conclusions say many of the older studies were done before white cells were filtered out of whole-blood donations. White cells in the “host” body help fight disease and infection. But when they’re put into someone else, they can suppress the immune system.
More recent studies have shown that transfusion-related reactions have fallen since blood suppliers began washing white blood cells from blood. However, Dr. Aryeh Shander, clinical professor of anesthesiology, medicine and surgery at Mount Sinai School of Medicine in New York, says that while there has been an unquestionable reduction in fever rates, “the rest is debated.”
Shander helped create the bloodless medicine and surgery program at Englewood Hospital and Medical Center in Englewood, New Jersey. He says that “old habits die hard” and that too many doctors believe “something bad will happen” if patients don’t have a certain volume of blood in their system.

Hemoglobin transfusions can be risky

The biggest driver of red blood-cell transfusions is hemoglobin, the protein in red blood cells that ferries oxygen from the lungs to tissues and cells throughout the body. Too little hemoglobin, and the person becomes anemic.
Red blood cells are frequently transfused during cardiac surgery, prostate surgery, joint replacements and in patients bleeding from their intestinal tracts.
But, once removed from the body, red cells undergo changes in their shape and function. Their membranes deteriorate; some cells burst, releasing free hemoglobin, which mops up nitric oxide, the chemical that helps blood vessels relax. There are now growing concerns that “older” red cells stored for longer than a few weeks lose some of their ability to transport oxygen — the very reason they’re transfused. In Canada, red cells are stored for up to 42 days.
Dr. Paul Hebert, Critical Care Physician at The Ottawa Hospital on July 8, 2013, led a groundbreaking study which found that ICU patients who were transfused when they were only mildly anemic were more likely to die than patients who weren't transfused. (Chris Roussakis / Postmedia News)
Dr. Paul Hebert, Critical Care Physician at The Ottawa Hospital on July 8, 2013, led a groundbreaking study which found that ICU patients who were transfused when they were only mildly anemic were more likely to die than patients who weren’t transfused. (Chris Roussakis / Postmedia News)
When he was in medical school, Ottawa critical care specialist Dr. Paul Hebert, whose research has transformed transfusion practices worldwide, was taught that seriously ill patients need a high level of hemoglobin to keep diseased or damaged tissues alive. So ingrained was this belief that anesthesiologists and surgeons routinely began transfusing surgery patients if their hemoglobin dipped below a certain number (100 grams per litre of blood.)
In a landmark paper published in the New England Journal of Medicine, Hebert and his team found that patients who were only mildly below that hemoglobin cutoff, but who were treated aggressively with transfused blood nonetheless, were more likely to die, and had higher rates of organ failure, than patients whose doctors held back until their hemoglobin fell to lower levels.
“We found that, if you give less blood, you do better,” Hebert said. “We think that’s because many of the patients didn’t need it in the first place.”
In a study published in January 2013, Hebert and co-authors reviewed 19 trials involving more than 6,000 patients that compared higher versus lower hemoglobin thresholds in red-blood-cell transfusions. They found that patients could be transfused at hemoglobin levels of 70 or 80 grams per litre of blood without putting them at any increased risk for major complications such as pneumonia, stroke, infection, or death.
If doctors were to use the lower thresholds, “I think you can reduce blood use in many settings by at least half,” said lead author Dr. Jeffrey Carson, chief of the division of general internal medicine at Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey.
A recent review of blood transfusions at three Ontario hospitals found that the pre-transfusion hemoglobin levels were higher than the recommended thresholds for many patients.
Some transfusion rates have been falling since the province established a network of blood transfusion co-ordinators in 25 hospitals. A major thrust of the program is to treat patients with anemia — low hemoglobin — before surgery “so that we avoid having to transfuse them when they bleed,” said Dr. John Freedman, medical director of the program and professor emeritus at the University of Toronto.
British Columbia created the first transfusion registry in Canada in 1999; it remains one of the largest in North America. The database tracks every unit of blood that gets transfused into someone in B.C or the Yukon.
Within the year, The Ottawa Hospital hopes to have a computerized system in place to capture where blood is going, which patients are being transfused and their hemoglobin levels at transfusion.
According to the Canadian Blood Services, Canada is at the lower end of blood use worldwide, and experts say it would be dangerous to attempt to cut transfusion rates to near zero. As well, demand for blood is expected to grow as the population ages, because older people use more blood. While Jehovah’s Witnesses have taught doctors that the body can compensate for extraordinarily low levels of hemoglobin, levels that are too low mean the cells and tissues in the brain and other vital organs become starved of oxygen.
Hebert has watched Jehovah’s Witnesses die for refusing to be transfused, an experience that leaves the medical team feeling helpless. “But you can’t force your values on someone else,” he says.
Hebert says more research and education is needed to help doctors decide how long they can safely wait before ordering blood, how much blood they should give and when to hold off giving any blood at all.
“The problem is that we don’t have the data,” Hebert said. “In many cases, we just don’t know.”

By the numbers

900,000 – Average number of units of blood collected each year in Canada, outside Quebec. (Hema-Quebec, which runs the province’s blood system, collected 252,340 units of blood from donors in 2011/2012).
850,000 – Estimated units of red blood cells transfused into patients in Canada in 2011/2012.
More than 2.5 million – Number of bottles of blood collected in Canada during Second World War to help soldiers and war victims.
5 – Average number of litres of blood in a person’s body.
450 milliliters – Amount of blood that goes into a single donation. Though it is frequently referred to as a “pint,” a blood donation is 450 mL rather than the 570 mL in a pint. The human body begins replenishing the lost blood within hours, and finishes the job within 56 days.
20,000 – Number of blood clinics run by Canadian Blood Services each year.
42 days – Maximum shelf life for red blood cells collected through blood donations. Most blood is sent to hospitals within a week. Platelets have only a five-day shelf life.
One – Number of hours, on average, it takes to donate blood.
17 – Minimum legal age for donating blood in Canada.
7  – Number of times a year a healthy person can donate blood (i.e. every 56 days).
Every 60 seconds – How often, on average, someone in Canada receives blood or a blood product.
4 – Number of days after which the supply of blood products for high-demand blood groups would run out if Canadians stopped donating blood.
3 – Number of lives that can be saved with one donation of blood. Whole blood donations are separated into red cells, platelets and plasma. Each component can be given to a different person.
52 per cent – Proportion of Canadians who say they or a family member have needed blood or blood products for surgery or for medical treatment.
One in 10 – Number of people admitted to hospital who receive blood.
54 per cent – Proportion of Canadians eligible to donate blood.
3.7 per cent – Proportion of Canadians who actually give blood.
One in three – Number of Canadians who do not know their blood type.
Two – Average number of units of blood transfused for hip replacement surgery.
50 – Average units of blood transfused to save the life of a car-crash victim.
2,000 – Number of Canadians infected with HIV from donated blood.
30,000 – Number of Canadians infected with hepatitis C.
1 in 8 million donations – Estimated risk of HIV today.
1 in 6.7 million donations – Estimated risk of hepatitis C.
1 in 1.7 million donations – Estimated risk of hepatitis B,
Sources: Canadian Blood Services, American Red Cross, Hema-Quebec

A brief history of blood

400 BC – Hippocrates postulates that the body is comprised of four “humours” — blood, phlegm, black and yellow bile — and that their imbalance causes disease.
1492 – Earliest recorded transfusion: As a remedy for a stroke suffered by Pope Innocent VIII, his doctor advises a blood transfusion. The blood of four young adults is transferred to the Pope. Donors and patient later all die.
1628 – British physician William Harvey discovers the circulation of blood.
1665 – First recorded successful blood transfusion. English physician Richard Lower keeps dog alive by transfusing blood from other dogs.
1667 – French physician Jean-Baptiste Denis transfuses blood from sheep into a patient. The patient survives.
1818 – British obstetrician James Blundell performs the first successful transfusion of human blood to a woman hemorrhaging after childbirth, using the woman’s husband as a donor.
1897 – Bram Stoker’s classic horror novel Dracula, about a blood-sucking being, is published.
1901 – Austrian physician Karl Landsteiner discovers the first three human blood groups – A, B and C (C later changed to O). AB, the fourth type is discovered two years later; the Rh blood group is discovered in 1939-1940.
1926 – The British Red Cross institutes the first human blood transfusion service in the world.
1945 – Canadians start giving blood to hospitals.
1947 – Canada establishes a national blood transfusion service; the first blood centre opens in Vancouver. By 1961, Canada has 16 blood centres serving every region of the country.
July 1981 – First cluster of AIDS identified in homosexuals in Los Angeles.
July 1982 – AIDS identified in hemophiliacs.
December 1982 – AIDS identified in blood transfusion recipients.
1983 – French virologist Luc Montagnier isolates the virus that causes AIDS. The Canadian Red Cross Society prohibits blood donations from men who have sex with men.
November 1985 – Red Cross starts screening all blood for HIV.
1987 – Guidelines in the U.S. and Canada encourage people who had transfusions to be tested for HIV.
October 1993 – The federal government authorizes the creation of a Commission of Inquiry on the Blood System in Canada. Justice Horace Krever is appointed as commissioner.
November 1997 – Justice Horace Krever releases his voluminous report on the tainted-blood scandal.
September 1998 – Canadian Red Cross gets out of the blood business, transferring assets to the Canadian Blood Services and Hema-Quebec.
1999 – Canadian Blood Services introduces its first deferral policy for Creutzfeldt-Jakob disease (variant CJD), the human equivalent of “mad cow” disease and announces that people can no longer donate blood if they have spent six months or more in the United Kingdom since 1980.
May 2013 – Canadian Blood Services loosens restrictions on blood donations from men who have sex with men, saying it will now accept donations from men who haven’t had sex with another man within the last five years. Before the change, men who had had sex with another man at any time since 1977 (the beginning of the AIDS epidemic in the U.S.) were turned away.
Sources: U.K. Blood Transfusion & Tissue Transplantation Services; AABB; Canadian Blood Services

Some more unsettled science.

Selection and Speciation: Why Darwinism Is False

Since then, biologists have found lots of direct evidence for natural selection. Coyne describes some of it, including an increase in average beak depth of finches on the Galápagos Islands and a change in flowering time in wild mustard plants in Southern California -- both due to drought. Like Darwin, Coyne also compares natural selection to the artificial selection used in plant and animal breeding.
But these examples of selection -- natural as well as artificial -- involve only minor changes within existing species. Breeders were familiar with such changes before 1859, which is why Darwin did not write a book titled How Existing Species Change Over Time; he wrote a book titled The Origin of Species by Means of Natural Selection. "Darwin called his great work On the Origin of Species," wrote Harvard evolutionary biologist Ernst Mayr in 1982, "for he was fully conscious of the fact that the change from one species into another was the most fundamental problem of evolution." Yet, Mayr had written earlier, "Darwin failed to solve the problem indicated by the title of his work." In 1997, evolutionary biologist Keith Stewart Thomson wrote: "A matter of unfinished business for biologists is the identification of evolution's smoking gun," and "the smoking gun of evolution is speciation, not local adaptation and differentiation of populations." Before Darwin, the consensus was that species can vary only within certain limits; indeed, centuries of artificial selection had seemingly demonstrated such limits experimentally. "Darwin had to show that the limits could be broken," wrote Thomson, "so do we."41
In 2004, Coyne and H. Allen Orr published a detailed book titled Speciation, in which they noted that biologists have not been able to agree on a definition of "species" because no single definition fits every case. For example, a definition applicable to living, sexually reproducing organisms might make no sense when applied to fossils or bacteria. In fact, there are more than 25 definitions of "species." What definition is best? Coyne and Orr argued that, "when deciding on a species concept, one should first identify the nature of one's 'species problem,' and then choose the concept best at solving that problem." Like most other Darwinists, Coyne and Orr favor Ernst Mayr's "biological species concept" (BSC), according to which "species are groups of interbreeding natural populations that are reproductively isolated from other such groups." In Why Evolution Is True, Coyne explains that the biological species concept is "the one that evolutionists prefer when studying speciation, because it gets you to the heart of the evolutionary question. Under the BSC, if you can explain how reproductive barriers evolve, you've explained the origin of species."42
Theoretically, reproductive barriers arise when geographically separated populations diverge genetically. But Coyne describes five "cases of real-time speciation" that involve a different mechanism: chromosome doubling, or "polyploidy."43 This usually follows hybridization between two existing plant species. Most hybrids are sterile because their mismatched chromosomes can't separate properly to produce fertile pollen and ovaries; occasionally, however, the chromosomes in a hybrid spontaneously double, producing two perfectly matched sets and making reproduction possible. The result is a fertile plant that is reproductively isolated from the two parents -- a new species, according to the BSC.
But speciation by polyploidy ("secondary speciation") has been observed only in plants. It does not provide evidence for Darwin's theory that species originate through natural selection, nor for the neo-Darwinian theory of speciation by geographic separation and genetic divergence. Indeed, according to evolutionary biologist Douglas J. Futuyma, polyploidy "does not confer major new morphological characteristics... [and] does not cause the evolution of new genera" or higher levels in the biological hierarchy.44
So secondary speciation does not solve Darwin's problem. Only primary speciation -- the splitting of one species into two by natural selection -- would be capable of producing the branching-tree pattern of Darwinian evolution. But no one has ever observed primary speciation. Evolution's smoking gun has never been found.45
Or has it?
In Why Evolution Is True, Coyne claims that primary speciation was observed in an experiment reported in 1998. Curiously, Coyne did not mention it in the 2004 book he co-authored with Orr, but his 2009 account of it is worth quoting in full:

We can even see the origin of a new, ecologically diverse bacterial species, all within a single laboratory flask. Paul Rainey and his colleagues at Oxford University placed a strain of the bacteria Pseudomonas fluorescens in a small vessel containing nutrient broth, and simply watched it. (It's surprising but true that such a vessel actually contains diverse environments. Oxygen concentration, for example, is highest on the top and lowest on the bottom.) Within ten days--no more than a few hundred generations--the ancestral free-floating 'smooth' bacterium had evolved into two additional forms occupying different parts of the beaker. One, called 'wrinkly spreader,' formed a mat on top of the broth. The other, called 'fuzzy spreader,' formed a carpet on the bottom. The smooth ancestral type persisted in the liquid environment in the middle. Each of the two new forms was genetically different from the ancestor, having evolved through mutation and natural selection to reproduce best in their respective environments. Here, then, is not only evolution but speciation occurring in the lab: the ancestral form produced, and coexisted with, two ecologically different descendants, and in bacteria such forms are considered distinct species. Over a very short time, natural selection in Pseudomonas yielded a small-scale 'adaptive radiation,' the equivalent of how animals or plants form species when they encounter new environments on an oceanic island.46

But Coyne omits the fact that when the ecologically different forms were placed back into the same environment, they "suffered a rapid loss of diversity," according to Rainey. In bacteria, an ecologically distinct population (called an "ecotype") may constitute a separate species, but only if the distinction is permanent. As evolutionary microbiologist Frederick Cohan wrote in 2002, species in bacteria "are ecologically distinct from one another; and they are irreversibly separate."47 The rapid reversal of ecological distinctions when the bacterial populations in Rainey's experiment were put back into the same environment refutes Coyne's claim that the experiment demonstrated the origin of a new species.
Exaggerating the evidence to prop up Darwinism is not new. In the Galápagos finches, average beak depth reverted to normal after the drought ended. There was no net evolution, much less speciation. Yet Coyne writes in Why Evolution Is True that "everything we require of evolution by natural selection was amply documented" by the finch studies. Since scientific theories stand or fall on the evidence, Coyne's tendency to exaggerate the evidence does not speak well for the theory he is defending. When a 1999 booklet published by The U. S. National Academy of Sciences called the change in finch beaks "a particularly compelling example of speciation," Berkeley law professor and Darwin critic Phillip E. Johnson wrote in The Wall Street Journal: "When our leading scientists have to resort to the sort of distortion that would land a stock promoter in jail, you know they are in trouble."48
So there are observed instances of secondary speciation -- which is not what Darwinism needs -- but no observed instances of primary speciation, not even in bacteria. British bacteriologist Alan H. Linton looked for confirmed reports of primary speciation and concluded in 2001: "None exists in the literature claiming that one species has been shown to evolve into another. Bacteria, the simplest form of independent life, are ideal for this kind of study, with generation times of twenty to thirty minutes, and populations achieved after eighteen hours. But throughout 150 years of the science of bacteriology, there is no evidence that one species of bacteria has changed into another."49
Notes
40 Coyne, Why Evolution Is True, p. 116.
Darwin, The Origin of Species, Chapter IV (p. 70). Available online (2009) here.
H. B. D. Kettlewell, "Darwin's Missing Evidence," Scientific American 200 (March, 1959): 48-53.

41 Ernst Mayr, The Growth of Biological Thought (Cambridge, MA: Harvard University Press, 1982), p. 403.
Ernst Mayr, Populations, Species and Evolution (Cambridge, MA: Harvard University Press, 1963), p. 10.
Keith Stewart Thomson, "Natural Selection and Evolution's Smoking Gun," American Scientist 85 (1997): 516-518.

42 Jerry A. Coyne & H. Allen Orr, Speciation (Sunderland, MA: Sinauer Associates, 2004), p. 25-39.
Coyne, Why Evolution Is True, p. 174.

43 Coyne, Why Evolution Is True, p. 188.
44 Douglas J. Futuyma, Evolution (Sunderland, MA: Sinauer Associates, 2005), p. 398.
45 Wells, The Politically Incorrect Guide to Darwinism and Intelligent Design, Chapter Five ("The Ultimate Missing Link"), pp. 49-59.
46 Coyne, Why Evolution Is True, pp. 129-130.
47 Paul B. Rainey & Michael Travisano. "Adaptive radiation in a heterogeneous environment,"Nature 394 (1998): 69-72.
Frederick M. Cohan, "What Are Bacterial Species?" Annual Review of Microbiology 56 (2002): 457-482. Available online (2009) here.

48 Coyne, Why Evolution Is True, p. 134.
National Academy of Sciences, Science and Creationism: A View from the National Academy of Sciences, Second edition (Washington, DC: National Academy of Sciences Press, 1999), Chapter on "Evidence Supporting Biological Evolution," p. 10. Available online (2009) here.
Phillip E. Johnson, "The Church of Darwin," The Wall Street Journal (August 16, 1999): A14. Available online (2009) here.

49 Alan H. Linton, "Scant Search for the Maker," The Times Higher Education Supplement (April 20, 2001), Book Section, p. 29.